Peggy Lillis Foundation’s annual Summit has often created the opportunity for C. diff advocates to connect with clinicians, researchers, and industry representatives. We feared that taking it virtual would hinder those connections. Turns out we needn’t have worried. Among the connections made at this year’s Summit was one between Idaho-based …
April 2020 marked a decade since we lost Peggy Lillis to a community-acquired C. difficile infection and founded the Peggy Lillis Foundation (PLF) to combat this disease. It also marked our fifth National C. diff Advocacy Summit. Initially planned to once again be held in Washington, DC, due to COVID-19 PLF …
In the midst of the COVID-19 pandemic, we have new appreciation for the role of public health. While our hospitals and other health facilities are turned toward preparing for the worst part of the outbreak in the U.S., we also know that those of you battling C. diff infections still …
Last month our executive director and two members of our Advocates Council, Christina Fuhrman and Eric Petrosinelli, joined the Pew Charitable Trusts “Stand Up to Superbugs” fly-in. They joined 37 other Americans from all across the country to meet with the representatives to share their superbug stories and expertise and …
Fecal microbiota transplant (FMT) as a treatment for C. difficile infections has skyrocketed over the past decade. While it has saved tens of thousands of lives, FMT remains controversial and the Food and Drug Administration (FDA) has been slow to formalize its regulatory status. This has left doctors, scientists, drug …
